Clinical Trial Detail

NCT ID NCT03772925
Title Pevonedistat and Belinostat in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

myelodysplastic syndrome

acute myeloid leukemia

Therapies

Belinostat + MLN4924

Age Groups: adult senior

No variant requirements are available.